Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Announces Positive Results In Dose-Finding Pediatric Study Of Macimorelin

April 6 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS ANNOUNCES POSITIVE RESULTS IN
DOSE-FINDING
PEDIATRIC STUDY OF MACIMORELIN
    * AETERNA ZENTARIS-RESULTS GIVE CLINICAL FRAMEWORK TO
ADVANCE CO'S
PEDIATRIC INVESTIGATION PLAN FOR MACIMORELIN AS GROWTH HORMONE
DEFICIENCY DIAGNOSTIC
    * AETERNA ZENTARIS INC - PEDIATRIC PK/PD PROFILE OF
MACIMORELIN
PROVED TO BE IN EXPECTED RANGE AND GENERALLY COMPARABLE TO DATA
IN ADULTS
    * AETERNA ZENTARIS INC - PLANNED SAFETY AND EFFICACY STUDY
P02
EXPECTED TO COMMENCE IN Q4 2020

Source text for Eikon:  ID:nGNX5Sr74C 
Further company coverage:  AEZS.TO 

 (((Reuters.Briefs@thomsonreuters.com);))

Recent news on COSCIENS Biopharma

See all news